CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso Pharma to Develop New Hemp-Based Lozenge Product, page-5

  1. 751 Posts.
    lightbulb Created with Sketch. 92
    This line seems tactically placed away from the headlines on the second page...

    The Company notes, however, that it has not undertaken any independent studies on the efficacy of its new lozenge product in the treatment of SARS-CoV-2, and therefore makes no therapeutic claims in this regard.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.